160 related articles for article (PubMed ID: 26644282)
1. Evaluation of Antifungal Efficacy of 0.1% and 0.25% Riboflavin with UVA: A Comparative In Vitro Study.
Bilgihan K; Kalkanci A; Ozdemir HB; Yazar R; Karakurt F; Yuksel E; Otag F; Karabicak N; Arikan-Akdagli S
Curr Eye Res; 2016 Aug; 41(8):1050-1056. PubMed ID: 26644282
[TBL] [Abstract][Full Text] [Related]
2. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis.
Özdemir HB; Kalkancı A; Bilgihan K; Göçün PU; Öğüt B; Karakurt F; Erdoğan M
Acta Ophthalmol; 2019 Feb; 97(1):e91-e96. PubMed ID: 29862655
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial efficacy of corneal cross-linking in vitro and in vivo for Fusarium solani: a potential new treatment for fungal keratitis.
Zhu Z; Zhang H; Yue J; Liu S; Li Z; Wang L
BMC Ophthalmol; 2018 Mar; 18(1):65. PubMed ID: 29499665
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis.
Wei A; Wang K; Wang Y; Gong L; Xu J; Shao T
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1443-1452. PubMed ID: 31041523
[TBL] [Abstract][Full Text] [Related]
5.
Kunt Z; Yağmur M; Kandemir H; Harbiyeli I; Erdem E; Kalkancı A; De Hoog GS; Ilkit M
Curr Eye Res; 2020 Jan; 45(1):7-11. PubMed ID: 31403321
[No Abstract] [Full Text] [Related]
6. Corneal Cross-linking as an Adjunct for The Management of Refractory Fungal Keratitis.
Bamdad S; Khalili MR; Khosravi A; Attarzade A; Movahedan H; Nejabat M
Middle East Afr J Ophthalmol; 2020; 27(4):204-209. PubMed ID: 33814816
[TBL] [Abstract][Full Text] [Related]
7. Comparison between three different high fluence UVA levels in corneal collagen cross-linking for treatment of experimentally induced fungal keratitis in rabbits.
Awad R; Hafezi F; Ghaith AA; Baddour MM; Awad K; Abdalla M; Sheta E; Sultan GM; Elmassry A
Eur J Ophthalmol; 2022 Jul; 32(4):1907-1914. PubMed ID: 35384782
[TBL] [Abstract][Full Text] [Related]
8. Collagen Cross-Linking in the Management of Microbial Keratitis.
Bonzano C; Di Zazzo A; Barabino S; Coco G; Traverso CE
Ocul Immunol Inflamm; 2019; 27(3):507-512. PubMed ID: 29308960
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Corneal Cross-Linking for Treatment of Fungal Keratitis: Using Confocal Laser Scanning Microscopy on an Ex Vivo Human Corneal Model.
Alshehri JM; Caballero-Lima D; Hillarby MC; Shawcross SG; Brahma A; Carley F; Read ND; Radhakrishnan H
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6367-6373. PubMed ID: 27898982
[TBL] [Abstract][Full Text] [Related]
10. Photochemical eradication of methicillin-resistant Staphylococcus aureus by blue light activation of riboflavin.
Makdoumi K; Goodrich R; Bäckman A
Acta Ophthalmol; 2017 Aug; 95(5):498-502. PubMed ID: 28205348
[TBL] [Abstract][Full Text] [Related]
11. Treatment of fungal keratitis from Fusarium infection by corneal cross-linking.
Galperin G; Berra M; Tau J; Boscaro G; Zarate J; Berra A
Cornea; 2012 Feb; 31(2):176-80. PubMed ID: 22081155
[TBL] [Abstract][Full Text] [Related]
12. Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.
Arboleda A; Miller D; Cabot F; Taneja M; Aguilar MC; Alawa K; Amescua G; Yoo SH; Parel JM
Am J Ophthalmol; 2014 Jul; 158(1):64-70.e2. PubMed ID: 24792103
[TBL] [Abstract][Full Text] [Related]
13. Collagen Cross-linking With Photoactivated Riboflavin (PACK-CXL) for Bacterial Keratitis After Small Incision Lenticule Extraction (SMILE).
Chan TC; Chow VW; Jhanji V
J Refract Surg; 2017 Apr; 33(4):278-280. PubMed ID: 28407169
[TBL] [Abstract][Full Text] [Related]
14. Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model.
Kalkanci A; Yesilirmak N; Ozdemir HB; Unal EA; Erdoğan M; Seker T; Tum AE; Karakus AK; Hizel K; Bilgihan K
Cornea; 2018 Nov; 37(11):1463-1467. PubMed ID: 30161054
[TBL] [Abstract][Full Text] [Related]
15. Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration.
Kashiwabuchi RT; Carvalho FR; Khan YA; Hirai F; Campos MS; McDonnell PJ
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):521-7. PubMed ID: 23180236
[TBL] [Abstract][Full Text] [Related]
16. Impact of fluorescein on the antimicrobial efficacy of photoactivated riboflavin in corneal collagen cross-linking.
Richoz O; Gatzioufas Z; Francois P; Schrenzel J; Hafezi F
J Refract Surg; 2013 Dec; 29(12):842-5. PubMed ID: 24404606
[TBL] [Abstract][Full Text] [Related]
17. Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology.
Price MO; Tenkman LR; Schrier A; Fairchild KM; Trokel SL; Price FW
J Refract Surg; 2012 Oct; 28(10):706-13. PubMed ID: 23062001
[TBL] [Abstract][Full Text] [Related]
18. Current and Future Applications of Photoactivated Chromophore for Keratitis-Corneal Collagen Cross-Linking (PACK-CXL): An Overview of the Different Treatments Proposed.
Abbouda A; Abicca I; Alió JL
Semin Ophthalmol; 2018; 33(3):293-299. PubMed ID: 27093581
[TBL] [Abstract][Full Text] [Related]
19. Corneal Cross-linking as an Adjuvant Therapy in the Management of Recalcitrant Deep Stromal Fungal Keratitis: A Randomized Trial.
Uddaraju M; Mascarenhas J; Das MR; Radhakrishnan N; Keenan JD; Prajna L; Prajna VN
Am J Ophthalmol; 2015 Jul; 160(1):131-4.e5. PubMed ID: 25841317
[TBL] [Abstract][Full Text] [Related]
20. Accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking as a first-line and sole treatment in early fungal keratitis.
Tabibian D; Richoz O; Riat A; Schrenzel J; Hafezi F
J Refract Surg; 2014 Dec; 30(12):855-7. PubMed ID: 25437486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
